comparemela.com

Latest Breaking News On - Myeloid cells - Page 1 : comparemela.com

Researchers identify potential new approaches for early detection and treatment of atherosclerosis

Actym to Present Preclinical Data on Clinical Candidate ACTM-838 at 38th SITC Annual Meeting

Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today that it will present preclinical data of its lead asset, ACTM-838, in a poster presentation at the 2023 38th Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California. The presentation will feature data examining the tumor-specific enrichment and payload delivery of ACTM-838 in multiple tumor models.

Prostate cancer breakthrough as drug resistance reversed by stopping hijacking of cells

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.